Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
JS-006 by Shanghai Junshi Biosciences for Non-Small Cell Lung Cancer: Likelihood of Approval
JS-006 is under clinical development by Shanghai Junshi Biosciences and currently in Phase II for Non-Small Cell Lung Cancer. According...
JS-006 by Shanghai Junshi Biosciences for Hepatocellular Carcinoma: Likelihood of Approval
JS-006 is under clinical development by Shanghai Junshi Biosciences and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData,...
JS-006 by Shanghai Junshi Biosciences for Solid Tumor: Likelihood of Approval
JS-006 is under clinical development by Shanghai Junshi Biosciences and currently in Phase II for Solid Tumor. According to GlobalData,...